Health Cabinet Secretary Susan Nakhumicha says Kenya remain committed in strengthening collaboration among governments, the scientific community, the private sector, and international organizations in an effort to improve its pandemic response.
Speaking in South Korea at the opening of the World Bio Summit, Nakhumicha said Kenya is set to collaborate with International Vaccine Institute to support BioVax develop safe, effective, and affordable vaccines for vulnerable populations.
During the summit, Nakhumicha held a meeting with a delegation of leaders from the International Vaccine Institute (IVI), including Director General Jerome Kim, Business Development Manager Junhee Lee, and Head of Global Affairs and Communications Youngmi Cho.
The CS affirmed Kenya’s commitment to host the IVI continental office, thereby enhancing the country’s capacity in vaccine prevention, preparedness, and response to outbreaks, epidemics, or pandemics.
The summit aims to bring together representatives from governments, the scientific community, the private sector, and international organizations involved in vaccine and biotechnology responses.
Spanning Monday through Tuesday, the summit will gather around 200 participants, including health ministers from several nations, to discuss strategies for bolstering global vaccine production and biotechnology capabilities.